Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy

BACKGROUND: The latest practice guidelines from the American College of Cardiology/American Heart Association recommend the prescription of an ACE-i for patients presenting with non-ischemic cardiomyopathy when left ventricular ejection fraction (LVEF) falls below 40%. OBJECTIVE: To determine if the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stalens, Caroline, Motté, Leslie, Béhin, Anthony, Ben Yaou, Rabah, Leturcq, France, Bassez, Guillaume, Laforêt, Pascal, Fontaine, Bertrand, Ederhy, Stéphane, Masingue, Marion, Saadi, Malika, Louis, Sarah Leonard, Berber, Nawal, Stojkovic, Tanya, Duboc, Denis, Wahbi, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385526/
https://www.ncbi.nlm.nih.gov/pubmed/33814458
http://dx.doi.org/10.3233/JND-200620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385526/
https://www.ncbi.nlm.nih.gov/pubmed/33814458
http://dx.doi.org/10.3233/JND-200620

Ejemplares similares